Pelin G. Ersan

机构：University of Copenhagen, Bilkent University, Copenhagen University Hospital · ORCID：0000-0003-3637-4090

发表论文 40 篇 · 总被引 810 次 · h-index 11

代表论文

• Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer (2024 · Cell Death and Disease · 被引 32)
• Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer (2024 · Cell Death and Differentiation · 被引 23)
• Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer (2023 · Nature Communications · 被引 13)
• Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Why emerging leaders should focus on being good postdoctoral supervisors (2025 · FEBS Letters · 被引 1)
• Assessing the significance of CCNE1 overexpression in triple negative breast cancer (2026 · Clinical & Translational Oncology)